We learned at the May 30 webcast that the preclinical study in Glioblastoma had started, which means that it's been approximately 6 months since then. I would think that the study may have completed.
The annual report indicates that "Upon completion of the study, the academic institutions will provide the Company with a research report outlining the study results, and they will have the right to publish and present the study results."
I look forward to hearing more.
(15)
(0)
CytoDyn Inc (CYDY) Stock Research Links
There are no guarantees in investing. No one should consider these pages or posts to be financial advice. Everyone has a responsibility to verify and thoroughly learn more than what is referenced or written here, and everyone must take responsibility for their own investing decisions.